TIA and AIS patients had higher levels of EVs derived from endothelial (CD146+; Figure 4A) and activated endothelial cells (CD62E+; Figure 4B) at 5- and 30-days compared to onset levels. This evidence concerns the gene SELE and transient ischemic attack.